AdvancednervousPhysiology
Myasthenia Gravis: Autoimmune Failure at the Neuromuscular Junction
Overview
Myasthenia gravis is an autoimmune disorder in which antibodies attack nicotinic acetylcholine receptors at the neuromuscular junction. With fewer functional receptors, the end-plate potential shrinks; during repeated activity it falls below threshold and muscle fibers drop out, producing weakness that worsens with use and recovers with rest. This page explains the immunological mechanism and its physiological consequences. Educational only, not medical advice.
Learning objectives
- Explain how anti-AChR antibodies impair neuromuscular transmission.
- Describe why weakness is fatigable and which muscles are affected first.
- Explain the role of the thymus (educational).
- Describe how transmission-enhancing therapy works mechanistically (educational).
Process steps
IgG antibodies target nicotinic receptors on the muscle end plate, cross-linking and marking them.
Accelerated internalization, complement-mediated membrane destruction, and direct blockade drastically cut functional receptor numbers.
The end-plate potential shrinks toward threshold; single twitches still succeed at rest but the margin is gone.
Normal presynaptic ACh rundown with successive impulses pushes end-plate potentials below threshold in more fibers: visible fatigability.
The releasable ACh pool replenishes during rest, end-plate potentials recover, and strength returns until the next sustained effort.
Key variables
| Variable | Unit | Typical range | Role |
|---|---|---|---|
| Functional receptor reduction | relative | as low as ~10% of normal | Severe receptor loss explains why the safety factor collapses in advanced disease. |
The autoimmune attack
In most patients, IgG autoantibodies target the nicotinic acetylcholine receptors on the muscle end plate. They damage transmission three ways: they cross-link receptors, accelerating their internalization and degradation; they activate complement, which destroys the folded postsynaptic membrane and reduces its receptor-dense area; and they directly block the ACh binding site on some receptors. The result is a drastic reduction in functional receptors, sometimes to a tenth of normal, eroding the neuromuscular junction's safety factor.
From fewer receptors to fatigable weakness
Normally the end-plate potential is several times larger than needed (the safety factor), so transmission never fails. In myasthenia, the shrunken end-plate potential may still exceed threshold at rest, so initial contractions look normal. But with repeated firing, presynaptic ACh release declines slightly with each impulse (normal rundown), and the already-small end-plate potential now falls below threshold in more and more fibers. Fibers drop out progressively: this is fatigable weakness, the clinical hallmark. Rest restores the releasable ACh pool and strength returns.
Fewer receptors shrink the safety factor; normal ACh rundown with repeated firing then pushes end-plate potentials below threshold. Rest rebuilds the ACh pool and weakness reverses.
Which muscles fail first
The disease typically announces itself in the extraocular muscles: fluctuating double vision and drooping eyelids (ptosis), because these small motor units have naturally low safety factors and fire constantly. It may remain ocular or generalize to bulbar muscles (speech, swallowing, facial expression), limb muscles (proximal more than distal), and neck extensors. Respiratory muscle involvement can cause myasthenic crisis, a medical emergency. The pattern is always fluctuating weakness, not fixed paralysis.
The thymus connection
The thymus, which normally trains immune tolerance, is abnormal in most patients: hyperplastic with germinal centers in younger patients, or harboring a thymoma in some older ones. Thymic tissue appears to sustain the autoimmune response, which is why thymectomy (surgical removal) can induce improvement or remission in selected patients. This link between a lymphoid organ and a junction disease illustrates how autoimmunity bridges systems.
Diagnosis through physiology (educational)
Diagnosis exploits the mechanism: repetitive nerve stimulation shows a decremental response (each successive muscle response shrinks as fibers drop out), single-fiber EMG shows increased jitter, and antibody assays detect anti-AChR or anti-MuSK antibodies. The historical edrophonium test briefly prolonged ACh action and transiently restored strength. These are clinical procedures described for understanding, not instructions.
Treatment logic follows the mechanism (educational)
Therapy is rationally layered: acetylcholinesterase inhibitors (like pyridostigmine) prolong ACh in the cleft, partially compensating for fewer receptors; immunosuppressants and steroids reduce antibody production; plasma exchange or IV immunoglobulin rapidly remove or neutralize antibodies in crises. None of this is treatment advice; it shows how each intervention maps onto the pathophysiology described above.
Key points
- Autoantibodies reduce functional ACh receptors via internalization, complement damage, and blockade.
- Loss of safety factor makes transmission fail with repeated firing: fatigable weakness.
- Extraocular muscles are usually affected first (low safety factor, constant use).
- Thymic abnormalities sustain the autoimmune response; thymectomy can help selected patients.
- Repetitive stimulation shows a decremental response as fibers drop out.
Common misconceptions
✓ Truth: The muscle fibers are intrinsically normal; the defect is in transmission at the neuromuscular junction. That is why strength can be fully normal at rest and fail only with activity.
✓ Truth: It fluctuates characteristically: worse with sustained activity and late in the day, better after rest. Fixed weakness suggests a different process.
Practice questions
Q1. In myasthenia gravis, autoantibodies primarily target:
- Presynaptic Ca2+ channels
- Postsynaptic nicotinic ACh receptors
- Muscle actin
- Spinal motor neurons
IgG antibodies attack the muscle end plate's nicotinic receptors, reducing their number through internalization, complement-mediated damage, and blockade.
Q2. The fatigable pattern occurs because:
- Muscles run out of ATP
- End-plate potentials fall below threshold with repeated firing
- Nerves stop conducting
- Tropomyosin is damaged
With fewer receptors the safety factor is lost; normal ACh rundown during repeated firing then drops end-plate potentials below threshold fiber by fiber.
Q3. Repetitive nerve stimulation in myasthenia typically shows:
- Incremental response
- Decremental response
- No change
- Complete block immediately
Successive stimuli produce progressively smaller muscle responses as more fibers' end-plate potentials fall below threshold: the decremental pattern.
Click a question to reveal the answer and explanation.
Frequently asked questions
Why do eyelids droop first in myasthenia?
Extraocular and levator palpebrae motor units are small, fire continuously to hold gaze and lids, and have low safety factors, so receptor loss affects them earliest and most visibly.
What is a myasthenic crisis?
Severe weakness of respiratory and bulbar muscles compromising breathing or swallowing, often triggered by infection or medication changes. It is a medical emergency requiring intensive care.
Why does rest restore strength?
Rest allows the presynaptic terminal to replenish its readily releasable ACh pool, so end-plate potentials rise back above threshold in previously failing fibers.